Drug Type Small molecule drug |
Synonyms Atorvastatin Calcium/Hydrochlorothiazide/Aspirin/Valsartan |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), COX inhibitors(Cyclooxygenases inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC7H8ClN3O4S2 |
InChIKeyJZUFKLXOESDKRF-UHFFFAOYSA-N |
CAS Registry58-93-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Phase 3 | IR | 01 Feb 2011 | |
Cardiovascular Diseases | Phase 3 | IR | 01 Feb 2011 | |
Cardiovascular Diseases | Phase 2 | IR | 01 Feb 2011 |